Movement Disorders Neurologist, University of Kentucky

Movement Disorders Neurologist
Neurology - General, Neurology - Movement Disorders, Academic Med
Lexington, Kentucky

Position Summary
The University of Kentucky College of Medicine (UK HealthCare) is seeking a board certified/eligible neurologist with additional expertise in movement disorders to join the highly-regarded Department of Neurology. Qualified candidates will have advanced training and expertise in movement disorders, in addition to being able to care for the broad spectrum of neurological disorders. Leadership opportunities exist for well-qualified candidates. Candidates with interest in resident and fellow education are encouraged to apply. The incoming neurologist will be based at in the UK Department of Neurology, a principal component of the Kentucky Neuroscience Institute, with inpatient facilities in the flagship UK Albert B. Chandler Hospital, a state-of-the-art facility in which UK HealthCare recently invested $532 million for a 1.2 million sq. ft. addition which effectively doubled hospital bed count.


Amelia J. Anderson-Mooney, PhD

Assistant Professor of Neurology and Neurosurgery

Michael R. Dobbs, MD, MHCM

Associate Chief Medical Officer; Stroke Neurologist

Julie A. Gurwell, PA-C-C, PhD

Assistant Professor of Neurology

John T. Slevin, MD, MBA, FAAN

Director of Clinical Research at the UK Parkinson’s Disease Research Center of Excellence; UK Holsinger Parkinson’s Disease Professor of Neuroscience

Craig G. van Horne, MD, PhD

Director, Deep Brain Stimulator Center; Associate Professor of Neurosurgery

Movement Disorders Program
The UK Movement Disorders Clinic specializes in the evaluation and treatment of disorders of gait, coordination and other aspects of movement. Patients are seen with diseases such as Parkinson's disease, Parkinson-plus syndromes, torticollis and other dystonias, Huntington's disease, tremors, spinocerebellar syndromes, myoclonus, and all other neurodegenerative illnesses involving the cerebellum and basal ganglia. Patients also are evaluated for blepharospasm, hemifacial spasm and cerebellar ataxias. Specialized care, including botulinum toxin is provided for all types of dystonia including torticollis, writer's cramp, musician's cramp, sialorrhea and focal dystonia in the limbs. Surgical pallidotomy is available for appropriate patients with Parkinson's disease. Experimental trials to evaluate the efficiency of new drugs, including glial-derived neurotrophic factor (GDNF) in Parkinson's patients is being developed. . UK’s multidisciplinary movement disorders team is comprised of neurologists with special expertise in movement disorders, pharmacists, nurses, social workers and a patient services coordinator. Each of these health care professionals plays a key role in making your visit as efficient and comfortable as possible. Founded in 1989, the UK Botulinum Toxin (Botox) Treatment Clinic is the state's oldest and largest botulinum treatment clinic. In addition to Botox Treatment, the program offers Deep Brain Stimulation procedures, among other options.

Kentucky Parkinson’s Disease Center
UK HealthCare and the American Parkinson’s Disease Association (APDA) have partnered to create the Kentucky Parkinson's Disease Information and Referral Center. The center provides physician and service referrals and educational programs, and it develops and maintains support groups across the state. We also host patient and caregiver information sessions.

Department Overview
UK Neurology, led by Dr. Larry Goldstein, boasts some of the leading clinical and research centers in the country for cerebrovascular disease, epilepsy and Alzheimer’s disease, including a Joint Commission certified Comprehensive Stroke Center, Level 4 NAEC Comprehensive Epilepsy Center, and NIA-designated Alzheimer’s Disease Research Center (ADRC) that has become an international referral center and research powerhouse. The Department of Neurology offers ACGME-accredited adult and child neurology residency program and three post-residency neurology fellowships. The nationally recognized UK Department of Neurology is comprised of a team of more than 30 neurologists and other providers dedicated to patient care, research, and education, and is actively expanding. The UK Department of Neurology is a principal component the Kentucky Neuroscience Institute with inpatient services provided at the UK Chandler Hospital, one of the fast growing academic medical centers in the country. Additionally, The UK Comprehensive Stroke Center and Norton Healthcare joined with area hospitals to help develop the first community-based stroke program in the region.

UK Healthcare & College of Medicine
UK Healthcare is a fully integrated health system that includes the UK Colleges of Medicine, Health Sciences, Dentistry, Nursing, Pharmacy, and Public Health, allowing for ease of access and collaborations among peers – UK owns all of the hospitals within the UK HealthCare system. New COM leadership is in place with a new Dean, Robert DiPaola, MD and CMO, Philip Chang, MD. UK COM leadership has identified the neurosciences as 1 of 4 strategic pillars of growth, which supports further expansion and growth. In 2011, UK opened a $532 million, 1.2 million sq. ft. expansion pavilion in its Albert B. Chandler Hospital, which will help to serve a 25,000 square mile area with a catchment population of 8 million people. Additional UK Healthcare System facilities:

  • Kentucky Children’s Hospital (KCH): KCH is the only facility in Central and Eastern Kentucky dedicated to the expert medical and surgical care of infants, children, and adolescents. KCH admits approximately 5,000 patients per year and houses the state’s only Level 1 Pediatric Trauma & Tertiary Referral Center and Level 4 NAEC Comprehensive Epilepsy Center. It has 66 NICU beds, currently expanding to an 80-single family bed unit, and 12 PICU beds.
  • UK Albert B. Chandler Hospital: Two patient floors with a total of 128 beds (48 intensive care and 80 acute care beds in all private rooms) were the first to open: Floor 6 for neuroscience services and Floor 7 for trauma and acute care surgery patients. The hospital also houses the state’s only adult Level 1 Trauma & Tertiary Referral Center and Level 4 NAEC Comprehensive Epilepsy Center.
  • Shriner’s Children’s Hospital: Located in Lexington, is relocating to the UK medical campus. Shriner’s Hospital will bring a wealth of Cerebral Palsy and Muscular Dystrophy patients, increasing opportunities for collaborative care, while approximately 75% of Shriner’s patient base has child neurology needs. Additionally, all of Shriner’s orthopedists will become UK faculty.
  • Good Samaritan: 302 beds, more than 600 clinical and ancillary staff, and a medical staff of more than 600 physicians, 50,000sq ft medical office space, and the 2nd-largest orthopedic and joint replacement program in KY.
  • Cardinal Hill Rehabilitation Hospital: After inpatient care, patients are referred to the Cardinal Hill Rehabilitation Hospital for neurological rehabilitation therapy as appropriate.

For fiscal year 2016, UK COM reached $129.2 million in grants and contracts, including $66 million in NIH funding. Coupled with the UK Center for Clinical and Translational Science’s recent Clinical and Translational Science Award from the NIH, UK is part of a select national biomedical research consortium and is on the way to becoming a top 20 research institution.

Lexington, Kentucky
UK is located in Lexington, KY, and with a population of about 310,000 people, it is the second-largest city in the state and 61st in the country. Based in the heart of the Kentucky bluegrass region, Lexington is home to numerous horse and stock farms that all lend to its apt “Horse Capital of the World” nickname. While horseracing is a billion-dollar industry, Lexington has also emerged as one of the leading American cities in economic growth due to a concerted effort to diversify the area's economy toward more manufacturing and high-technology ventures. More than 100 major companies have headquarters or facilities located in Lexington, including Toyota, Xerox, Lexmark International, Lockheed-Martin and IBM, all Fortune 500 companies. Lexington ranks 6th on “America’s Best Value Cities,” and 10th and 13th in education and literacy, respectively.

How to apply

In an overall effort to identify the most qualified potential candidates, UK HealthCare has retained the services of Academic Med Physician Recruiters. For further information about the Movement Disorders Specialist opportunity or to submit your CV, please visit: and contact Austin Taylor, the Search Consultant overseeing the recruitment for this opportunity (214.396.5024).